Bio-Rad said that the Visia platform offers a standardized and automated workflow needed by laboratories to handle ever-increasing immunofluorescence workloads.
Kindstar has been granted exclusive rights to market the SLE-Key Rule-Out test in China, which will be the initial product offering stemming from the partnership.
Quanterix's Simoa single-molecule detection method combined with high-affinity antibodies detected minute levels of problematic interferon alpha proteins, a study said.
